Addex Pharmaceuticals Announces Board Changes
Vincent Lawton appointed to Vice-Chairman
18-Aug-2011
- Switzerland
Mr. Lawton, who was previously Managing Director of Merck Sharp & Dohme (MSD) U.K. and Vice President of MSD Europe, both subsidiaries of Merck & Co., Inc., has served on the Addex Board since April 2009.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.